162 related articles for article (PubMed ID: 22502699)
1. TP53 codon 72 polymorphism and risk of acute leukemia.
Dunna NR; Vure S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S; Vishnupriya S
Asian Pac J Cancer Prev; 2012; 13(1):347-50. PubMed ID: 22502699
[TBL] [Abstract][Full Text] [Related]
2. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
[TBL] [Abstract][Full Text] [Related]
3. Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia.
Dunna NR; Vure S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S; Vishnupriya S
Asian Pac J Cancer Prev; 2013; 14(4):2221-4. PubMed ID: 23725116
[TBL] [Abstract][Full Text] [Related]
4. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
[TBL] [Abstract][Full Text] [Related]
5. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
6. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
7. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
8. Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India.
Rao DN; Anuradha C; Vishnupriya S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S
Asian Pac J Cancer Prev; 2010; 11(4):1063-6. PubMed ID: 21133625
[TBL] [Abstract][Full Text] [Related]
9. No association between the Trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a South Indian population.
Suresh K; Chandirasekar R; Kumar BL; Venkatesan R; Sasikala K
Asian Pac J Cancer Prev; 2010; 11(6):1749-53. PubMed ID: 21338227
[TBL] [Abstract][Full Text] [Related]
10. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
11. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
[TBL] [Abstract][Full Text] [Related]
12. Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.
Xiong X; Wang M; Wang L; Liu J; Zhao X; Tian Z; Wang J
Leuk Res; 2009 Nov; 33(11):1454-8. PubMed ID: 19423162
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
[TBL] [Abstract][Full Text] [Related]
14. Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia.
Chauhan PS; Ihsan R; Yadav DS; Mishra AK; Bhushan B; Soni A; Kaushal M; Devi TR; Saluja S; Gupta DK; Mittal V; Saxena S; Kapur S
DNA Cell Biol; 2011 Jan; 30(1):39-46. PubMed ID: 20731606
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility.
Berköz M; Yalin S
Leuk Res; 2009 Jul; 33(7):919-23. PubMed ID: 19144407
[TBL] [Abstract][Full Text] [Related]
16. MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study.
El-Danasouri NM; Ragab SH; Rasheed MA; Ali El Saadany Z; Abd El-Fattah SN
Ann Clin Lab Sci; 2014; 44(4):449-54. PubMed ID: 25361931
[TBL] [Abstract][Full Text] [Related]
17. High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia.
Chauhan PS; Ihsan R; Mishra AK; Yadav DS; Saluja S; Mittal V; Saxena S; Kapur S
Environ Mol Mutagen; 2012 Oct; 53(8):619-30. PubMed ID: 22930568
[TBL] [Abstract][Full Text] [Related]
18. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
19. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
[TBL] [Abstract][Full Text] [Related]
20. The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.
Ruan XL; Li S; Meng XY; Geng P; Gao QP; Ao XB
Medicine (Baltimore); 2015 Sep; 94(38):e1588. PubMed ID: 26402821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]